• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes.花生四烯乙醇胺是肿瘤细胞和T淋巴细胞迁移的内源性抑制剂。
Cancer Immunol Immunother. 2004 Aug;53(8):723-8. doi: 10.1007/s00262-004-0509-9. Epub 2004 Mar 18.
2
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.内源性大麻素对神经生长因子Trk受体和催乳素受体的抑制作用导致人乳腺癌和前列腺癌细胞增殖受到抑制。
Endocrinology. 2000 Jan;141(1):118-26. doi: 10.1210/endo.141.1.7239.
3
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.内源性大麻素花生四烯乙醇胺可抑制人乳腺癌细胞的增殖。
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8375-80. doi: 10.1073/pnas.95.14.8375.
4
Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.2-甲基花生四烯酰基-(2'-氟乙基)酰胺对白细胞功能和白细胞介素-2基因表达的抑制作用,2-甲基花生四烯酰基-(2'-氟乙基)酰胺是内源性大麻素受体配体花生四烯乙醇胺的一种稳定类似物。
Toxicol Appl Pharmacol. 2005 Jun 1;205(2):107-15. doi: 10.1016/j.taap.2004.09.013. Epub 2005 Jan 1.
5
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.内源性大麻素2-花生四烯酸甘油酯是通过人类2型大麻素受体的完全激动剂:花生四烯酸乙醇胺的拮抗作用。
Mol Pharmacol. 2000 May;57(5):1045-50.
6
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.内源性大麻素花生四烯乙醇胺是一种脂质信使,可通过造血细胞系中不依赖大麻素受体的途径激活细胞生长。
FEBS Lett. 1998 Apr 3;425(3):419-25. doi: 10.1016/s0014-5793(98)00275-0.
7
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.CB1和CB2受体在大麻素对星形胶质细胞培养物中脂多糖诱导的一氧化氮释放的抑制作用中的作用。
J Neurosci Res. 2002 Mar 15;67(6):829-36. doi: 10.1002/jnr.10165.
8
CB1 cannabinoid receptor-mediated cell migration.
J Pharmacol Exp Ther. 2000 Jul;294(1):204-9.
9
Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors.
Neuroreport. 2002 Apr 16;13(5):593-6. doi: 10.1097/00001756-200204160-00011.
10
Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.内源性大麻素通过 CB2 受体主要抑制原代人 T 淋巴细胞的增殖和细胞因子释放。
PLoS One. 2010 Jan 14;5(1):e8688. doi: 10.1371/journal.pone.0008688.

引用本文的文献

1
Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges.通过调节信号通路和应对临床挑战来探索大麻素在癌症治疗中的潜力。
Discov Oncol. 2024 Sep 27;15(1):490. doi: 10.1007/s12672-024-01356-8.
2
Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery.神经保护及其他:CB1 和 CB2 受体在中风康复中的核心作用。
Int J Mol Sci. 2023 Nov 24;24(23):16728. doi: 10.3390/ijms242316728.
3
Use of Cannabis and Cannabinoids for Treatment of Cancer.大麻和大麻素在癌症治疗中的应用。
Cancers (Basel). 2022 Oct 20;14(20):5142. doi: 10.3390/cancers14205142.
4
Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation.大麻素对肿瘤微环境的治疗潜力:肿瘤转化中的分子开关。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221096766. doi: 10.1177/15347354221096766.
5
Impact of Cannabinoid Compounds on Skin Cancer.大麻素化合物对皮肤癌的影响。
Cancers (Basel). 2022 Mar 31;14(7):1769. doi: 10.3390/cancers14071769.
6
Anandamide-Modulated Changes in Metabolism, Glycosylation Profile and Migration of Metastatic Melanoma Cells.花生四烯乙醇胺调节转移性黑色素瘤细胞的代谢、糖基化谱及迁移变化。
Cancers (Basel). 2022 Mar 10;14(6):1419. doi: 10.3390/cancers14061419.
7
"The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained.“同一枚硬币的两面”——医用大麻、大麻素与免疫:利弊解析
Pharmaceutics. 2022 Feb 10;14(2):389. doi: 10.3390/pharmaceutics14020389.
8
Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes.大麻素受体CB2R的抗炎和促自噬作用:1型糖尿病中的调节可能性
Front Pharmacol. 2022 Jan 18;12:809965. doi: 10.3389/fphar.2021.809965. eCollection 2021.
9
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer.肠道炎症和结直肠癌中大麻素与内源性大麻素系统的变化
Cancers (Basel). 2021 Aug 28;13(17):4353. doi: 10.3390/cancers13174353.
10
Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.CB2受体选择性激动剂JWH133的药理特性、治疗潜力及分子机制
Front Pharmacol. 2021 Jul 30;12:702675. doi: 10.3389/fphar.2021.702675. eCollection 2021.

本文引用的文献

1
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.肿瘤细胞的迁移、侵袭与转移:神经递质介导的导航
Lancet Oncol. 2004 Apr;5(4):254-8. doi: 10.1016/S1470-2045(04)01431-7.
2
The cannabinoid system and immune modulation.大麻素系统与免疫调节。
J Leukoc Biol. 2003 Oct;74(4):486-96. doi: 10.1189/jlb.0303101. Epub 2003 Jul 1.
3
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells.神经递质对MDA-MB-468人乳腺癌细胞化学运动性和趋化性的影响。
Breast Cancer Res Treat. 2003 Jul;80(1):63-70. doi: 10.1023/A:1024491219366.
4
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.花生四烯乙醇胺对人前列腺癌细胞系的抗增殖和凋亡作用:表皮生长因子受体下调和神经酰胺产生的影响
Prostate. 2003 Jun 15;56(1):1-12. doi: 10.1002/pros.10190.
5
2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism.2-花生四烯酸甘油酯通过大麻素CB2受体依赖性机制诱导分化为巨噬细胞样细胞的HL-60细胞和人外周血单核细胞迁移。
J Biol Chem. 2003 Jul 4;278(27):24469-75. doi: 10.1074/jbc.M301359200. Epub 2003 Apr 23.
6
A new role for GABA: inhibition of tumor cell migration.γ-氨基丁酸的新作用:抑制肿瘤细胞迁移。
Trends Pharmacol Sci. 2003 Apr;24(4):151-4. doi: 10.1016/S0165-6147(03)00052-X.
7
Effects of delta-9-tetrahydrocannabinol on human immune function and host defense.
Chem Phys Lipids. 2002 Dec 31;121(1-2):229-39. doi: 10.1016/s0009-3084(02)00159-7.
8
Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells.Δ9-四氢大麻酚调节活化的人T细胞中的Th1/Th2细胞因子平衡。
J Neuroimmunol. 2002 Dec;133(1-2):124-31. doi: 10.1016/s0165-5728(02)00370-3.
9
The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells.神经递质γ-氨基丁酸是SW 480结肠癌细胞迁移的抑制性调节因子。
Cancer Res. 2002 Nov 15;62(22):6467-9.
10
Neurotransmitters are regulators for the migration of tumor cells and leukocytes.神经递质是肿瘤细胞和白细胞迁移的调节因子。
Cancer Immunol Immunother. 2002 Nov;51(9):467-82. doi: 10.1007/s00262-002-0300-8. Epub 2002 Jul 27.

花生四烯乙醇胺是肿瘤细胞和T淋巴细胞迁移的内源性抑制剂。

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes.

作者信息

Joseph Jan, Niggemann Bernd, Zaenker Kurt S, Entschladen Frank

机构信息

Institute of Immunology, Witten/Herdecke University, Stockumer Str. 10, 58448, Witten, Germany.

出版信息

Cancer Immunol Immunother. 2004 Aug;53(8):723-8. doi: 10.1007/s00262-004-0509-9. Epub 2004 Mar 18.

DOI:10.1007/s00262-004-0509-9
PMID:15034673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11032818/
Abstract

Cell migration is of paramount importance in physiological processes such as immune surveillance, but also in the pathological processes of tumor cell migration and metastasis development. The factors that regulate this tumor cell migration, most prominently neurotransmitters, have thus been the focus of intense investigation. While the majority of neurotransmitters have a stimulatory effect on cell migration, we herein report the inhibitory effect of the endogenous substance anandamide on both tumor cell and lymphocyte migration. Using a collagen-based three-dimensional migration assay and time-lapse videomicroscopy, we have observed that the anandamide-mediated signals for CD8+ T lymphocytes and SW 480 colon carcinoma cells are each mediated by distinct cannabinoid receptors (CB-Rs). Using the specific agonist docosatetraenoylethanolamide (DEA), we have observed that the norepinephrine-induced migration of colon carcinoma cells is inhibited by the CB1-R. The SDF-1-induced migration of CD8+ T lymphocytes was, however, inhibited via the CB2-R, as shown by using the specific agonist JWH 133. Therefore, specific inhibition of tumor cell migration via CB1-R engagement might be a selective tool to prevent metastasis formation without depreciatory effects on the immune system of cancer patients.

摘要

细胞迁移在诸如免疫监视等生理过程中至关重要,在肿瘤细胞迁移和转移发展的病理过程中也同样重要。因此,调节这种肿瘤细胞迁移的因素,尤其是神经递质,一直是深入研究的焦点。虽然大多数神经递质对细胞迁移有刺激作用,但我们在此报告内源性物质花生四烯乙醇胺对肿瘤细胞和淋巴细胞迁移均有抑制作用。使用基于胶原蛋白的三维迁移试验和延时视频显微镜,我们观察到花生四烯乙醇胺介导的CD8 + T淋巴细胞和SW 480结肠癌细胞信号分别由不同的大麻素受体(CB-Rs)介导。使用特异性激动剂二十二碳四烯酰乙醇胺(DEA),我们观察到去甲肾上腺素诱导的结肠癌细胞迁移受到CB1-R的抑制。然而,如使用特异性激动剂JWH 133所示,SDF-1诱导的CD8 + T淋巴细胞迁移通过CB2-R受到抑制。因此,通过CB1-R参与特异性抑制肿瘤细胞迁移可能是一种选择性工具,可防止转移形成,而不会对癌症患者的免疫系统产生不利影响。